These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12127467)

  • 1. Women in addictions treatment: comparing VA and community samples.
    Davis TM; Carpenter KM; Malte CA; Carney M; Chambers S; Saxon AJ
    J Subst Abuse Treat; 2002 Jul; 23(1):41-8. PubMed ID: 12127467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of women seeking intensive outpatient substance use treatment in the VA.
    Stecker T; Han X; Curran GM; Booth BM
    J Womens Health (Larchmt); 2007 Dec; 16(10):1478-84. PubMed ID: 18062763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special Services for Women in Substance Use Disorders Treatment: How Does the Department of Veterans Affairs Compare with Other Providers?
    Heslin KC; Gable A; Dobalian A
    Womens Health Issues; 2015; 25(6):666-72. PubMed ID: 26329259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in service utilization among Operations Enduring Freedom, Iraqi Freedom, and New Dawn Veterans Affairs patients with severe mental illness and substance use disorders.
    Painter JM; Brignone E; Gilmore AK; Lehavot K; Fargo J; Suo Y; Simpson T; Carter ME; Blais RK; Gundlapalli AV
    Psychol Serv; 2018 Feb; 15(1):11-20. PubMed ID: 28517950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment.
    Saxon AJ; Malte CA; Sloan KL; Baer JS; Calsyn DA; Nichol P; Chapko MK; Kivlahan DR
    Med Care; 2006 Apr; 44(4):334-42. PubMed ID: 16565634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for substance abuse and psychiatric disorders among women patients in a VA Health Care System.
    Davis TM; Bush KR; Kivlahan DR; Dobie DJ; Bradley KA
    Psychiatr Serv; 2003 Feb; 54(2):214-8. PubMed ID: 12556603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in substance use disorders.
    Brady KT; Randall CL
    Psychiatr Clin North Am; 1999 Jun; 22(2):241-52. PubMed ID: 10385931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity.
    Calsyn DA; Saxon AJ; Bush KR; Howell DN; Baer JS; Sloan KL; Malte CA; Kivlahan DR
    Drug Alcohol Depend; 2004 Nov; 76(2):165-71. PubMed ID: 15488340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in substance abuse treatment and barriers to care among persons with substance use disorders with and without comorbid major depression.
    Chen LY; Strain EC; Crum RM; Mojtabai R
    J Addict Med; 2013; 7(5):325-34. PubMed ID: 24091763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of a gender-focused addiction model versus 12-step facilitation for women veterans.
    Najavits LM; Enggasser J; Brief D; Federman E
    Am J Addict; 2018 Apr; 27(3):210-216. PubMed ID: 29596724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use disorders in individuals with body dysmorphic disorder.
    Grant JE; Menard W; Pagano ME; Fay C; Phillips KA
    J Clin Psychiatry; 2005 Mar; 66(3):309-16; quiz 404-5. PubMed ID: 15766296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Individualized Addictions Consultation Team Residential Program: A Creative Solution for Integrating Care for Veterans With Substance Use Disorders Too Complex for Other Residential Treatment Programs.
    Keating S; Larsen SE; Collingwood J; Smith HM
    J Dual Diagn; 2021; 17(2):172-179. PubMed ID: 33583351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive adherence among women Veterans with mental illness and substance use disorder.
    Callegari LS; Zhao X; Nelson KM; Borrero S
    Contraception; 2015 May; 91(5):386-92. PubMed ID: 25636807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year mental health service use and course of remission in patients with substance use and posttraumatic stress disorders.
    Ouimette PC; Moos RH; Finney JW
    J Stud Alcohol; 2000 Mar; 61(2):247-53. PubMed ID: 10757135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidity and severity of dependence on substance users: how it impacts on their health-related quality of life?
    Lozano ÓM; Rojas AJ; Fernández Calderón F
    J Ment Health; 2017 Apr; 26(2):119-126. PubMed ID: 27128492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs.
    Friedmann PD; Zhang Z; Hendrickson J; Stein MD; Gerstein DR
    J Gen Intern Med; 2003 Jan; 18(1):1-8. PubMed ID: 12534757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment setting and baseline substance use severity interact to predict patients' outcomes.
    Tiet QQ; Ilgen MA; Byrnes HF; Harris AH; Finney JW
    Addiction; 2007 Mar; 102(3):432-40. PubMed ID: 17298651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuity of care practices and substance use disorder patients' engagement in continuing care.
    Schaefer JA; Ingudomnukul E; Harris AH; Cronkite RC
    Med Care; 2005 Dec; 43(12):1234-41. PubMed ID: 16299435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of residential treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; MacMaster SA; Seiters J
    J Psychoactive Drugs; 2013; 45(2):122-31. PubMed ID: 23909000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.